BIOTRONIK SE & Co. KG, (BIOTRONIK ), a company focused in manufacturing cardiovascular medical devices, announced the European launch of its new Evia pacemaker series and several new products to expand its bradycardia portfolio.
New Bradycardia portfolio
BIOTRONIK continues its product innovation stream with the launch of a completely new bradycardia product portfolio, including the Evia pacemaker series, the new Siello pacing leads as well as a new external pacemaker, Reocor, and a new pacing system analyzer, Reliaty.
Evia – Wireless patient monitoring & remote follow-up
The company claims that Evia is the first and only pacemaker with complete, wireless remote monitoring and follow-up capabilities. Patients with an Evia pacemaker can be remotely monitored through the proven BIOTRONIK Home Monitoring wireless system with only one annual in-clinic visit.
Evia – A complete pacemaker system
The company claims that Evia incorporates unique innovations for every step of advanced patient management from implant to follow-up. The small-sized pacemakers with extended longevities also provide several automatic functions to ensure a safe and convenient implantation procedure. In addition to the new platform features, Evia builds on established and proven innovations such as the unique Closed Loop Stimulation (CLS), which is the most advanced and physiological rate regulation algorithm available on the market today.
To meet individual patients’ needs, Evia also provides two new algorithms, Vp Suppression and IRSplus. These new Evia features are designed to reduce unnecessary ventricular pacing to a minimum, in order to lower patients’ risk of developing atrial fibrillation and heart failure.
Siello Pacing Leads – Quality design for complete reliability
The new Siello pacing leads have been designed by BIOTRONIK to ensure long-lasting reliability and patient safety. The ultra-thin lead body (5.6 French) with a new polyurethane coating enables more successful implantation especially in patients with smaller vessels and a more complex anatomy.
New technology platform to include MRI-conditional systems
Evia pacemakers are already designed to be MRI-conditional, and BIOTRONIK is planning to launch a new pacemaker-lead system which will be MRI-compatible under specific conditions during the first half of 2010.